Is generic atorvastatin as good as brand-name Lipitor? from the Harvard Health Letter

In the February issue of the Harvard Health Letter, Editor in Chief Dr. Anthony L. Komaroff answers a question that's on a lot of people's minds these days: is atorvastatin, the generic version of the cholesterol-lowering drug Lipitor, as good as the brand-name drug? Generic atorvastatin became available for the first time in November 2011 after Lipitor lost its patent protection. In his answer, Dr. Komaroff notes that the FDA is legally required to determine that generics are "bioequivalent" to brand-name drugs, which means they produce similar blood concentrations of the same chemicals.
To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »